211 related articles for article (PubMed ID: 33251781)
1. A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen.
Bak H; Kim H; Lee S; Lee Y; Bang SM; Lee YS
Yonsei Med J; 2020 Dec; 61(12):1060-1063. PubMed ID: 33251781
[TBL] [Abstract][Full Text] [Related]
2. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
[TBL] [Abstract][Full Text] [Related]
3. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
[TBL] [Abstract][Full Text] [Related]
4. Meropenem-induced vanishing bile duct syndrome.
Schumaker AL; Okulicz JF
Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
[TBL] [Abstract][Full Text] [Related]
5. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
Xie W; Wang Q; Gao Y; Pan CQ
BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
[TBL] [Abstract][Full Text] [Related]
6. Severe ductopenia and cholestasis from levofloxacin drug-induced liver injury: a case report and review.
Levine C; Trivedi A; Thung SN; Perumalswami PV
Semin Liver Dis; 2014 May; 34(2):246-51. PubMed ID: 24879988
[TBL] [Abstract][Full Text] [Related]
7. Cloxacillin-induced acute vanishing bile duct syndrome: A case study and literature review.
Faragalla K; Lau H; Wang HL; Liu J
Br J Clin Pharmacol; 2022 Oct; 88(10):4633-4638. PubMed ID: 35730139
[TBL] [Abstract][Full Text] [Related]
8. Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.
Oppenheimer AP; Koh C; McLaughlin M; Williamson JC; Norton TD; Laudadio J; Heller T; Kleiner DE; High KP; Morse CG
World J Gastroenterol; 2013 Jan; 19(1):115-21. PubMed ID: 23326172
[TBL] [Abstract][Full Text] [Related]
9. Two-dimensional ultrasonography and CEUS of a case with primary biliary cholangitis and vanishing bile duct syndrome.
Yu P; Zhou Y; Li X
J Clin Ultrasound; 2022 Nov; 50(9):1368-1372. PubMed ID: 36149806
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced Bile Duct Injury - A Short Review.
Dobreva I; Karagyozov P
Curr Drug Metab; 2020; 21(4):256-259. PubMed ID: 32310045
[TBL] [Abstract][Full Text] [Related]
11. Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission.
Aleem A; Al-Katari M; Alsaleh K; AlSwat K; Al-Sheikh A
Saudi J Gastroenterol; 2013; 19(6):286-9. PubMed ID: 24195983
[TBL] [Abstract][Full Text] [Related]
12. Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: a case report and review of the literature.
Nader K; Mok S; Kalra A; Harb A; Schwarting R; Ferber A
Tumori; 2013; 99(4):e164-8. PubMed ID: 24326854
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.
Bonkovsky HL; Kleiner DE; Gu J; Odin JA; Russo MW; Navarro VM; Fontana RJ; Ghabril MS; Barnhart H; Hoofnagle JH;
Hepatology; 2017 Apr; 65(4):1267-1277. PubMed ID: 27981596
[TBL] [Abstract][Full Text] [Related]
14. Meropenem-induced vanishing bile duct syndrome: A case report.
Zubarev A; Haji K; Li M; Tiruvoipati R; Botha J
J Int Med Res; 2020 Aug; 48(8):300060520937842. PubMed ID: 32865076
[TBL] [Abstract][Full Text] [Related]
15. Infliximab-Induced Vanishing Bile Duct Syndrome.
Eiswerth MJ; Heckroth MA; Ismail A; Gondim DD; Kaufman R
Cureus; 2022 Feb; 14(2):e21940. PubMed ID: 35273881
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
[TBL] [Abstract][Full Text] [Related]
17. [A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis].
Yoon JY; Min SY; Park JY; Hong SG; Park SJ; Paik SY; Park YM
Korean J Hepatol; 2008 Mar; 14(1):97-101. PubMed ID: 18367862
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory drug-induced vanishing bile duct syndrome treated with plasmapheresis.
Kawasaki Y; Matsubara K; Hashimoto K; Tanigawa K; Kage M; Iwata A; Nigami H; Fukaya T
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):e30-1. PubMed ID: 23969539
[No Abstract] [Full Text] [Related]
19. Lamotrigine-induced vanishing bile duct syndrome in a child.
Bhayana H; Appasani S; Thapa BR; Das A; Singh K
J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):e147-8. PubMed ID: 22008955
[No Abstract] [Full Text] [Related]
20. Vanishing bile duct syndrome after drug-induced liver injury.
Wasuwanich P; Choudry H; So JM; Lowry S; Karnsakul W
Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):102015. PubMed ID: 36067952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
